U.S. Protein Expression Market Size to Reach $3.2 Billion by 2030

The U.S. protein expression market is expected to grow at a CAGR of 11.8% during the forecast period 2023-2030, reaching a market size of $3.2 billion by 2030. The growth of the market is driven by the increasing demand for recombinant proteins for therapeutic and industrial applications.

Get a sample report for free:- https://www.vynzresearch.com/healthcare/us-protein-expression-market/request-sample

Key Drivers of Market Growth
The increasing number of chronic diseases is one of the key drivers of the growth of the U.S. protein expression market. Recombinant proteins are used to develop therapeutics for chronic diseases such as cancer, diabetes, and autoimmune disorders. The increasing number of life science and biopharmaceutical companies is also driving the growth of the market. These companies are using protein expression to develop new drugs and biologics.

Key Trends in the Market
The use of mammalian cell expression systems is one of the key trends in the U.S. protein expression market. Mammalian cell expression systems are more efficient in producing proteins that are similar to human proteins. This makes them ideal for developing therapeutics for human diseases.
Another key trend in the market is the increasing use of automation in protein expression. Automation can help to improve the efficiency and reproducibility of protein expression processes. This is leading to the adoption of automation by pharmaceutical and biotechnology companies.
For pre-purchase enquiry:- https://www.vynzresearch.com/enquiry-now/us-protein-expression-market

Key Players in the Market
Some of the key players in the U.S. protein expression market include:
New England Biolabs Inc.
Thermo Fisher Scientific Inc.
General Electric Company
QIAGEN N.V.
Takara Bio Inc.
Lonza Group Ltd.
Merck KGaA
Promega Corporation
Genscript Biotech Corporation
Agilent Technologies Inc.
Bio-Rad Laboratories Inc.

Market Segmentation
The U.S. protein expression market is segmented by product & services, systems, application, and end user.
By product & services, the market is segmented into expression systems, reagents, and kits.
By systems, the market is segmented into prokaryotic expression systems, yeast expression systems, mammalian cell expression systems, and insect cell expression systems.
By application, the market is segmented into therapeutics, research, and industries.
By end user, the market is segmented into academic research institutes, contract research organizations, pharmaceutical and biotechnology companies, and others.

Conclusion
The U.S. protein expression market is expected to grow at a significant CAGR during the forecast period. The growth of the market is driven by the increasing demand for recombinant proteins for therapeutic and industrial applications. The key trends in the market include the use of mammalian cell expression systems and the increasing use of automation. The key players in the market include New England Biolabs Inc., Thermo Fisher Scientific Inc., General Electric Company, and QIAGEN N.V.

About Us
Global market research company, VynZ Research provides research, analytics, and consulting services for business plans. We provide specialized market research reports based on information that was predicted and estimated by industry professionals and experts. In addition to industry experts, the top-down and bottom-up approaches, data triangulation, and other techniques enable the market research leader to validate the data and deliver a major market study.

Contact Us:
Address: H.O - 9591 Fontainebleau Blvd. 617 Miami Florida 33172 U.S.A
Phone: +91 9960 288 381
Toll Free:1 888 253 3960
Email: [email protected]
Website: www.vynzresearch.com